default author photo

Igor Gonda

Aradigm Corporation

3929 Point Eden Way

Hayward, CA 94545

United States

SCHOLARLY PAPERS

1

DOWNLOADS

67

TOTAL CITATIONS

1

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Two Randomised Controlled Trials of Inhaled Liposomal Ciprofloxacin (ARD-3150) in Patients with Non-Cystic Fibrosis Bronchiectasis and Chronic Lung Infection with Pseudomonas Aeruginosa

, Respiratory Medicine, Volume 7, Issue 3, March 2019, Pages 213-226, https://doi.org/10.1016/S2213-2600(18)30427-2
Number of pages: 72 Posted: 19 Sep 2018
Charles Haworth, Diana Bilton, James D. Chalmers, Angela M. Davis, Juergen Froehlich, Igor Gonda, Bruce Thompson, Adam Wanner and Anne E. O'Donnell
NHS Foundation Trust - Cambridge Centre for Lung Infection, Imperial College London - National Heart and Lung Institute, University of Dundee, Grifols Inc., Aradigm Corporation, Aradigm Corporation, Theta Hat Statistical Consultants LLC, University of Miami and Georgetown University
Downloads 67 (899,324)
Citation 1

Abstract:

Loading...

non-cystic fibrosis bronchiectasis; chronic lung infection; Pseudomonas aeruginosa; randomised controlled trials; ARD-3150; ciprofloxacin